Last updated: 1 December 2023 at 5:24pm EST

Dr. Frederick W. Telling Ph.D. Net Worth




The estimated Net Worth of Fred Telling is at least $673 Thousand dollars as of 30 November 2023. Dr Telling owns over 3,500 units of Oragenics Inc stock worth over $19,173 and over the last 18 years he sold OGEN stock worth over $545,872. In addition, he makes $107,500 as Exec. Chairman at Oragenics Inc.

Dr D OGEN stock SEC Form 4 insiders trading

Dr has made over 13 trades of the Oragenics Inc stock since 2010, according to the Form 4 filled with the SEC. Most recently he sold 3,500 units of OGEN stock worth $12,495 on 30 November 2023.

The largest trade he's ever made was selling 216,016 units of Oragenics Inc stock on 5 November 2010 worth over $84,246. On average, Dr trades about 17,121 units every 75 days since 2006. As of 30 November 2023 he still owns at least 38,345 units of Oragenics Inc stock.

You can see the complete history of Dr Telling stock trades at the bottom of the page.





Dr. Frederick W. Telling Ph.D. biography

Dr. Frederick W. Telling Ph.D. is the Exec. Chairman at Oragenics Inc.

What is the salary of Dr D?

As the Exec. Chairman of Oragenics Inc, the total compensation of Dr D at Oragenics Inc is $107,500. There are 3 executives at Oragenics Inc getting paid more, with Michael O. Sullivan CPA having the highest compensation of $297,210.



How old is Dr D?

Dr D is 69, he's been the Exec. Chairman of Oragenics Inc since . There are no older and 8 younger executives at Oragenics Inc.

What's Dr D's mailing address?

Fred's mailing address filed with the SEC is 4902 EISENHOWER BOULEVARD, , TAMPA, FL, 33634.

Insiders trading at Oragenics Inc

Over the last 12 years, insiders at Oragenics Inc have traded over $5,827,684 worth of Oragenics Inc stock and bought 8,095,027 units worth $13,189,855 . The most active insiders traders include Randal Jintrexon Corp Kirk, Joseph Hernandez, and Robert C Koski. On average, Oragenics Inc executives and independent directors trade stock every 60 days with the average trade being worth of $151,398. The most recent stock trade was executed by Fred Telling on 30 November 2023, trading 3,500 units of OGEN stock currently worth $12,495.



What does Oragenics Inc do?

oragenics is a publicly-traded biopharmaceutical company with a pipeline of unique proprietary technologies. offerings are based on the probiora3 technology and brands include evoraplus™ is a new, one-of-a-kind probiotic mint that naturally supports gum and tooth health while freshening breath and whitening teeth. oragenics has a number of products in discovery, preclinical and clinical development, with a concentration in the main therapeutic area of infectious diseases, in diagnostics, and in oral health.



What does Oragenics Inc's logo look like?

Oragenics Inc logo

Complete history of Dr Telling stock trades at CTI BioPharma Corp and Oragenics Inc

Date
#
Company
Insider
Trans.
Transaction
Shares Price per share Total value Shares after Source
30 Nov 2023 Fred Telling
Director
Sale 3,500 $3.57 $12,495
30 Nov 2023
38,345
17 Jun 2022 Fred Telling
Director
Buy 10,084 $0.29 $2,924
17 Jun 2022
1,010,000
23 May 2022 Fred Telling
Director
Buy 82,173 $0.29 $23,830
23 May 2022
999,916
18 May 2022 Fred Telling
Director
Buy 72,109 $0.28 $20,191
18 May 2022
852,025
30 Mar 2022 Fred Telling
Director
Buy 183,838 $0.36 $66,182
30 Mar 2022
779,916
29 Jun 2021 Fred Telling
Director
Option 156,540 $0.48 $75,139
29 Jun 2021
596,078
24 Nov 2020 Fred Telling
Director
Buy 100,000 $0.37 $37,000
24 Nov 2020
439,538
14 Nov 2014 Fred Telling
Director
Buy 27,000 $0.95 $25,650
14 Nov 2014
266,174
7 Mar 2014 Fred Telling
Director
Sale 72,095 $3.75 $270,356
7 Mar 2014
401,170
30 May 2013 Fred Telling
Director
Sale 64,798 $1.24 $80,350
30 May 2013
240,308
18 Sep 2012 Fred Telling
Director
Sale 18,874 $2.86 $53,980
18 Sep 2012
151,879
5 Nov 2010 Fred Telling
Director
Sale 216,016 $0.39 $84,246
5 Nov 2010
1,587,907
28 Jun 2010 Fred Telling
Director
Sale 105,823 $0.42 $44,446
28 Jun 2010
787,262


Oragenics Inc executives and stock owners

Oragenics Inc executives and other stock owners filed with the SEC include: